4
Changes in Ownership
Monopar Therapeutics Filed Acc 0001437749-23-019258
Chief Financial Officer gave up 5,104 shares (to pay taxes)
- Chief Financial Officer acquired 14,846 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Tsuchimoto Kim R Chief Financial Officer | 2023-06-30 | Option exercise | +14,846 | 36,578 | D | ||
| Tsuchimoto Kim R Chief Financial Officer | 2023-06-30 | Shares withheld for taxes | −5,104 | $0.86 | $4,364 | 31,474 | D |
| Derivatives | |||||||
| Tsuchimoto Kim R Chief Financial Officer | 2023-06-30 | Option exercise · Restricted Stock Units | −14,846 | 115,469 | D | ||
Loading xslF345X04/rdgdoc.xml…